CDKN2A copy number alteration in bladder cancer: integrative analysis in patient-derived xenografts and cancer patients
Article (May 2024)
The most recent citing publications are shown below. View all 178 publications that cite this research output on Dimensions.
The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer
Article in Nature Communications (February 2024)
The prognostic significance and clinical relevance of stem cell characteristic in bladder cancer
Article in Heliyon (February 2024)